Cargando…
Role of ursodeoxycholic acid in neonatal indirect hyperbilirubinemia: a systematic review and meta-analysis of randomized controlled trials
BACKGROUND: Neonatal jaundice is a transitional phenomenon affecting three out of five full-term newborns globally. Ursodeoxycholic acid could be beneficial in neonatal jaundice needing phototherapy. METHODS: We searched PubMed, EBSCO, ProQuest, and Cochrane Library up to August 21(st), 2021, for a...
Autores principales: | Lazarus, Glen, Francie, Jerrell, Roeslani, Rosalina Dewi, Saldi, Siti Rizny Fitriana, Oswari, Hanifah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575272/ https://www.ncbi.nlm.nih.gov/pubmed/36253867 http://dx.doi.org/10.1186/s13052-022-01372-w |
Ejemplares similares
-
Agreement test of transcutaneous bilirubin and bilistick with serum bilirubin in preterm infants receiving phototherapy
por: Rohsiswatmo, Rinawati, et al.
Publicado: (2018) -
Ursodeoxycholic acid as adjuvant treatment to phototherapy for neonatal hyperbilirubinemia: a systematic review and meta-analysis
por: Kuitunen, Ilari, et al.
Publicado: (2022) -
Effects of Two Different Doses of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates with Glucose-6-phosphate Dehydrogenase Deficiency Treated with Phototherapy: A Randomized Controlled Trial
por: Farhadi, Roya, et al.
Publicado: (2023) -
Comparison of the effect of ursodeoxycholic acid and multistrain synbiotic on indirect hyperbilirubinemia among neonates treated with phototherapy: A double-blind, randomized, placebo-controlled clinical trial study
por: Babaie, Elahe, et al.
Publicado: (2023) -
Indirect Neonatal Hyperbilirubinemia and the Role of Fenofibrate as an Adjuvant to Phototherapy
por: Shabo, Salam K., et al.
Publicado: (2023)